 |
|
|
| |
Interferon-Free Regimens of Ombitasvir and ABT-450/r With or Without Ribavirin in Patients With HCV Genotype 4 Infection: PEARL-I Study Results
|
| |
| |
Reported by Jules Levin
AASLD 2014 Nov 7-11 Boston
Stanislas Pol1, K Rajender Reddy2, Christophe Hezode3, Tarek Hassanein4, Patrick Marcellin5, Marina Berenguer6, Katarzyna Fleischer-Stepniewska7, Niloufar Mobashery8, Coleen Hall8, Christi ne Collins8, Regis A Vilchez8
1Groupe Hospitalier Cochin-Saint Vincent De Paul, Paris, France; 2University of Pennsylvania, Philadelphia, Pennsylvania, United States; 3Hôpital Henri Mondor, Créteil, France; 4Southern California Liver Centers and Southern California Research Center, Coronado, California, United States; 5Hopital Beaujon Inserm Crb3 - U773 - Service Hepatologie, Clichy, France; 6Hospital Universitario La Fe & CIBERehd, Valencia, Spain; 7Wroclaw Medical University, Wroclaw, Poland; 8AbbVie Inc., North Chicago, Illinois, United States
|
| |
|
|
|
|
|
